
SHOP
Product

CJC No Dac
Details:
A synthetic 29-amino-acid analogue of endogenous growth hormone-releasing hormone (GHRH). It is a modified version of the shortest fully functional GHRH fragment (GRF 1-29), featuring four specific D-amino acid substitutions at positions 2, 8, 15, and 27 that dramatically improve enzymatic stability against dipeptidyl peptidase-4 (DPP-4). Without the Drug Affinity Complex (DAC), it possesses a biological half-life of roughly 30 minutes, allowing it to mimic natural, sharp, physiological pulses of growth hormone (GH) from the anterior pituitary rather than inducing chronic, continuous elevation.
Key Benefits:
-
Pulsatile Growth Hormone Release: Binds selectively to pituitary GHRH receptors to produce sharp, natural peaks of endogenous GH release, respecting native somatostatin negative-feedback loops.
-
Preservation of Pituitary Health: Does not desensitize pituitary receptors or cause pituitary blebbing/hypertrophy associated with continuous GH secretagogues or high-dose exogenous GH.
-
Elevated IGF-1 & Cellular Regeneration: Drives sustained downstream hepatic secretion of insulin-like growth factor 1 (IGF-1), stimulating cellular repair, protein synthesis, and lean tissue maintenance.
-
Enhanced Lipolysis & Fat Metabolism: Facilitates mobilization of free fatty acids from adipose stores, supporting fat loss without impairing baseline insulin sensitivity.
-
Deep Sleep & CNS Recovery: Amplifies slow-wave (delta) sleep cycles when administered pre-bed, accelerating central nervous system recovery and nocturnal repair.
Ideal For:
-
Physiological body recomposition and anti-aging, offering the benefits of elevated GH/IGF-1 (skin elasticity, joint recovery, lean mass) without shutting down native hormone production.
-
Athletes and active individuals seeking improved workout recovery, deeper sleep architecture, and faster connective tissue remodeling.
-
Synergistic stacking protocols, particularly combined with a GHRP/GHS (such as Ipamorelin) to achieve a powerful, dual-pathway GH pulse.
